Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
JCO Precision Oncology
|
February 8, 2024
Association of Baseline Tumor-Specific Neoantigens and CD8<sup>+</sup> T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2021
<i>CDKN2A</i> Alterations and Response to Immunotherapy in Solid Tumors
Elio Adib, Amin H Nassar, Elie W Akl, et al.
Blood Advances
|
November 30, 2021
Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia
Sabrin Tahri, Tarek H Mouhieddine, Robert Redd, et al.
Cancer Cell
|
September 29, 2023
Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance
Donjeta Gjuka, Elio Adib, Kendra Garrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2021
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
Elio Adib, Katarzyna Klonowska, Krinio Giannikou, et al.
JCO Precision Oncology
|
February 16, 2022
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma
Bradley A McGregor, Wanling Xie, Elio Adib, et al.
Cell Reports
|
March 31, 2021
Trans-ethnic variation in germline variants of patients with renal cell carcinoma
Sarah Abou Alaiwi, Amin H Nassar, Elio Adib, et al.
Clinical Genitourinary Cancer
|
July 20, 2024
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
William Paul Skelton, Jack Masur, Jonathan Thomas, et al.
Cancer
|
February 1, 2024
Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database
Kripa Guram, Jiaming Huang, Christian Mouchati, et al.
Molecular Cancer Research : MCR
|
February 24, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes
Elio Adib, Amin H Nassar, Sarah Abou Alaiwi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
JCO Precision Oncology
|
February 8, 2024
Association of Baseline Tumor-Specific Neoantigens and CD8<sup>+</sup> T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2021
<i>CDKN2A</i> Alterations and Response to Immunotherapy in Solid Tumors
Elio Adib, Amin H Nassar, Elie W Akl, et al.
Blood Advances
|
November 30, 2021
Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia
Sabrin Tahri, Tarek H Mouhieddine, Robert Redd, et al.
Cancer Cell
|
September 29, 2023
Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance
Donjeta Gjuka, Elio Adib, Kendra Garrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2021
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
Elio Adib, Katarzyna Klonowska, Krinio Giannikou, et al.
JCO Precision Oncology
|
February 16, 2022
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma
Bradley A McGregor, Wanling Xie, Elio Adib, et al.
Cell Reports
|
March 31, 2021
Trans-ethnic variation in germline variants of patients with renal cell carcinoma
Sarah Abou Alaiwi, Amin H Nassar, Elio Adib, et al.
Clinical Genitourinary Cancer
|
July 20, 2024
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
William Paul Skelton, Jack Masur, Jonathan Thomas, et al.
Cancer
|
February 1, 2024
Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database
Kripa Guram, Jiaming Huang, Christian Mouchati, et al.
Molecular Cancer Research : MCR
|
February 24, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes
Elio Adib, Amin H Nassar, Sarah Abou Alaiwi, et al.
Page
of 5